重庆大学附属肿瘤医院Chongqing University Cancer Hospital

该疾病的证据

依据官方公开数据来源筛选

1. Colorectal cancer

   Chongqing 重庆市

   已发表研究

   • Total Neoadjuvant Therapy With Long-Course Radiotherapy Versus Chemoradiotherapy in High-Risk Locally Advanced Rectal Cancer (TNTCRT): A Multicenter, Randomized, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2026
   • Engineered E. coli biosensor with dual-module sensing and signal amplification for non-invasive detection of fecal bile acid salts in colorectal cancer screening. Analytica chimica acta, 2026

   PubMed 收录了 2 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Medical Oncology 获提名。

2. Breast cancer

   Chongqing 重庆市

   已发表研究

   • A ketogenic enzyme HMGCS2 drives malignant progression in HER2-negative breast cancer via RAB23-mediated β-catenin/TCF signaling and mediates Apatinib resistance. Life sciences, 2026
   • Systemic inflammation and white matter free water jointly explain chemotherapy-related cognitive decline in breast cancer. Brain, behavior, and immunity, 2026

   PubMed 收录了 2 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Medical Oncology 获提名。

3. Lung cancer

   Chongqing 重庆市

   已发表研究

   • MTAP deficiency enhances collective metastasis in non-small cell lung cancer via WNT3A methylation. Oncogene, 2026
   • MELTF Drives Lung Cancer Progression and Angiogenesis via HIF-1α-Mediated Activation of the VEGF Signaling Pathway. Molecular carcinogenesis, 2026

   PubMed 收录了 2 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Medical Oncology 获提名。

4. Liver cancer

   Chongqing 重庆市

   已发表研究

   • YAP-mediated mechanotransduction promotes hepatocellular carcinoma progression by targeting ATP1A1/CXCL1 axis. Acta pharmacologica Sinica, 2026

   PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Medical Oncology 获提名。

5. Cervical cancer

   Chongqing 重庆市

   国家临床重点专科

   • Gynecology（A 级） https://wsjkw.cq.gov.cn/zwgk_242/fdzdgknr/tzgg/gzgs/202405/t20240515_13209571.html

   已发表研究

   • Exosomal hnRNPA1-delivered miR-27a-3p inhibits the radiation-induced bystander effect in cervical cancer. Precision radiation oncology, 2026
   • Stichopus japonicus acidic mucopolysaccharide (SJAMP) exerts the tumor-suppressive activity in cervical cancer by targeting TFAP2A to downregulate CENPW. Cytotechnology, 2026

   PubMed 收录了 2 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Medical Oncology 获提名。

6. Prostate cancer

   Chongqing 重庆市

   已发表研究

   • Associations between CT-Based Body Composition and Cardiotoxicity and Overall Survival in Patients with Prostate Cancer. Academic radiology, 2026
   • A Multiplex RT-QPCR Assay of ONECUT2, EZH2, and BRCA2 for the Detection of Clinically Significant Prostate Cancer in Needle Biopsies. Cancers, 2026

   PubMed 收录了 2 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Medical Oncology 获提名。

7. Nasopharyngeal carcinoma

   Chongqing 重庆市

   国家临床重点专科

   • Radiation Oncology（B 级） https://www.cqch.cn/sitemap

   已发表研究

   • Developing personas for nutritional self-management in nasopharyngeal carcinoma patients: a qualitative study based on the Fogg Behavior Model. Frontiers in nutrition, 2026

   PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Medical Oncology 获提名。

8. Esophageal cancer

   Chongqing 重庆市

   已发表研究

   • miR-138-5p suppresses M2 macrophage polarization in esophageal squamous cell carcinoma via exosomes. Cellular signalling, 2026

   PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Medical Oncology 获提名。

9. Pancreatic cancer

   Chongqing 重庆市

   复旦专科声誉排行榜 2023

   • Medical Oncology 获提名 https://www.fdygs.com/news2023-1.aspx

   国家临床重点专科

   • Medical Oncology（B 级） https://www.cqch.cn/sitemap

10. Ovarian cancer

    Chongqing 重庆市

    国家临床重点专科

    • Gynecology（A 级） https://wsjkw.cq.gov.cn/zwgk_242/fdzdgknr/tzgg/gzgs/202405/t20240515_13209571.html

    同时上榜：在复旦榜中为 Medical Oncology 获提名。

11. Bone and soft tissue sarcoma

    Chongqing 重庆市

    复旦专科声誉排行榜 2023

    • Medical Oncology 获提名 https://www.fdygs.com/news2023-1.aspx

    国家临床重点专科

    • Medical Oncology（B 级） https://www.cqch.cn/sitemap